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Abstract
Background: Adenosine 5'-triphosphate (ATP) has a ubiquitous role in metabolism and a major
role in pain responses after tissue injury. We investigated the changes in basal and KCl-evoked ATP
release from rat dorsal root ganglia (DRG) after peripheral neuropathy induction by unilateral
sciatic nerve entrapment (SNE).
Results: After SNE, rats develop long-lasting decreases in ipsilateral hindpaw withdrawal
thresholds to mechanical and thermal stimulation. At 15–21 days after neuropathy induction,
excised ipsilateral L4-L5 DRG display significantly elevated basal extracellular ATP levels compared
to contralateral or control (naive) DRG. However, KCl-evoked ATP release is no longer observed
in ipsilateral DRG. We hypothesized that the differential SNE effects on basal and evoked ATP
release could result from the conversion of extracellular ATP to adenosine with subsequent
activation of adenosine A1 receptors (A1Rs) on DRG neurons. Adding the selective A1R agonist,
2-chloro-N6-cyclopentyladenosine (100 nM) significantly decreased basal and evoked ATP release
in DRG from naïve rats, indicating functional A1R activation. In DRG ipsilateral to SNE, adding a
selective A1R antagonist, 8-cyclopentyl-1,3-dipropylxanthine (30 nM), further increased basal ATP
levels and relieved the blockade of KCl-evoked ATP release suggesting that increased A1R
activation attenuates evoked ATP release in neurons ipsilateral to SNE. To determine if altered
ATP release was a consequence of altered DRG metabolism we compared O2 consumption
between control and neuropathic DRG. DRG ipsilateral to SNE consumed O2 at a higher rate than
control or contralateral DRG.
Conclusion: These data suggest that peripheral nerve entrapment increases DRG metabolism and
ATP release, which in turn is modulated by increased A1R activation.
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Certain neuropathic pain states that result from peripheral
nerve injury are associated with hyperexcitability of neu-
rons within sensory ganglia [1] and potentiated cross-exci-
tation among neighboring sensory neurons in the absence
of synaptic specializations [2]. Cross-excitation occurs
when discharge in one sensory neuron leads to a depolari-
zation in the cell bodies of adjacent passive neurons shar-
ing the same ganglion. Cross-excitation was reported to be
chemically mediated [3], but the identity of the chemical
mediator(s) is unknown. One possible candidate is ATP
which, in addition to its universal role in metabolism, is
released from stimulated sensory nerves [4]. There is com-
pelling evidence for exocytotic vesicular release of ATP
from neurons [5] and we have demonstrated Ca2+-
dependent ATP release within trigeminal ganglia after
neuronal stimulation in vivo, as well as from isolated
somata of trigeminal sensory neurons [6]. For ATP release
from non-neuronal cells, a variety of transport mecha-
nisms have been proposed, including but not limited to
ATP-binding cassette transporters and connexin
hemichannels, as well as vesicular release [5]. Extracellu-
lar ATP levels are controlled by both specific (ectonucle-
otidases) and nonspecific (ectoenzymes) enzymes with an
extracellularly-oriented catalytic site [7]. Other ectoen-
zymes also contribute to interconversion of nucleotides,
exerting control over the extracellular levels of various
nucleotides under physiological and pathophysiological
conditions [7]. Most studies examined ATP release after
bulk equilibration in extracellular samples with the luci-
ferin-luciferase assay (e.g., [6]). While highly sensitive,
these measurements greatly underestimate the true [ATP]
in the pericellular environment because of its rapid degra-
dation by ectonucleotidases and delayed diffusion due to
unstirred layer effects [8]. Recent studies have suggested
that true levels of ATP at the plasma membrane are under-
estimated by >20-fold with bulk phase measurements [9].
This should be considered when relating the extracellu-
larly measured concentrations of nucleotides to the effects
on their receptors.
ATP and related purines interact with three families of
purinergic receptors, the ionotropic P2X (7 receptors
cloned) and metabotropic P2Y (8 receptors cloned) and
P1 (4 receptors cloned) [8,10-12]. Given such tremen-
dous diversity of receptors and natural ligands it is not
surprising that ATP and related purines might be involved
in a wide spectrum of physiological and pathophysiolog-
ical activities, including nociception and chronic pain. For
example, ATP is a known algogen whose application by
iontophoresis to human skin elicits pain which is exagger-
ated by inflammation [13]. Application of ATP to dissoci-
ated neurons from rat sensory ganglia evokes inward
currents via the P2X ion channels, mainly P2X2/3 purino-
ceptors (P2XRs) [14,15]. Sensory neurons in culture form
synapses that appear to utilize ATP as their neurotransmit-
ter [16] and injury of skin cells near cultured neurons
results in P2XR activation on identified nociceptors [17].
The P2X3Rs are especially concentrated in small diameter
sensory neurons and their expression is differentially
affected in injured and uninjured neurons after peripheral
neuropathy induction [18-20]. Increased P2XR-mediated
signaling appears to contribute to sensory neuron hyper-
excitability after spinal nerve ligation [21,22], while func-
tional down-regulation of P2X3Rs alleviates neuropathy
symptoms [23]. The role of P2YRs in nociception and
chronic pain is less clear. Several studies have suggested
that ATP or uridine 5'-triphosphate (UTP) acting via
P2Y2Rs increase the excitability and action potential dis-
charge of sensory neurons, promote neuropeptide release
and axonal transport, and facilitate increased expression
of growth factors and neuropeptides by increasing the
phosphorylation of cAMP responsive element binding
protein [24]. However, there is also evidence that activa-
tion of P2Y1Rs on sensory neurons inhibits N-type volt-
age-gated Ca2+ channels (VGCCs) [25] and P2X3R
channels [26], while intrathecal administration of prefer-
ential agonists for P2Y1 and P2Y2/4 receptor subtypes
inhibits pain transmission [8,26]. Aside from the reported
increase in P2Y1R mRNA after sciatic nerve transection
[27], little is known about the plasticity of P2YR signaling
in neuropathic pain states.
Involvement of the P1 receptors in nociception and
chronic pain is well-established. A1 and A3R activation
usually results in antinociception and decreased neuro-
pathic pain symptoms, whereas A2A and A2BR activation
promotes nociception [10,28]. These receptors respond
selectively to extracellular adenosine produced from two
sources: 1) bidirectional facilitated diffusion and 2) extra-
cellular conversion of adenine nucleotides [10,29]. The
bidirectional transport of adenosine into and out of cells
is dependent on the intra and extracellular levels of ade-
nosine [30]. Blockade by transport inhibitors usually
increases extracellular adenosine levels. Inhibition of
cytosolic adenosine kinase also increases extracellular
adenosine [10,29]. Spinal nerve ligation enhances stimu-
lus-evoked increases in extracellular adenosine [31].
Inhibitors of adenosine kinase appear to decrease pain
symptoms of peripheral neuropathy in preclinical studies
[32].
By contrast, neuropathy-induced changes in extracellular
levels of ATP (an adenosine precursor), have not been
addressed. We used extracellular sampling from an in vitro
dorsal root ganglion (DRG) preparation [33] to assess
possible changes in ATP release from DRG in a rat model
of neuropathy induced by sciatic nerve entrapment [34]
and examine possible mechanisms and consequences of
such alterations. We found that basal extracellular [ATP]Page 2 of 13
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pressed in the injured DRG. Selective blockade of A1Rs
increased basal [ATP] and relieved the block of KCl-
evoked ATP release. We also demonstrated that cellular
metabolism was increased in the injured DRG, represent-
ing a potential source of neuropathy-induced increases in
extracellular [ATP].
Materials and methods
All experimental procedures were carried out in accord-
ance with the guidelines of the NIH on animal care and
University of California at Los Angeles animal research
committee.
Sciatic nerve entrapment (SNE)
Surgery was performed as described previously [34]. Adult
male Sprague-Dawley rats weighing 200–250 g were used.
Rats were anesthetized (pentobarbital 50 mg/kg, i.p.) or
alternatively with a mixture of isoflurane (1–3%), N2O
(50%), and O2 (inhalation) and the subsequent surgical
procedures were performed under sterile conditions. The
hair of the lower back and thigh of the rats was shaved and
the skin was sterilized with povidone-iodine solution. A
skin incision was made on one thigh and the sciatic nerve
exposed through blunt dissection of the overlying muscle.
Three Tygon® cuffs (length = 1 mm, outer diameter = 2.28
mm, inner diameter = 0.76 mm) were placed around the
exposed sciatic nerve. This tubing size allowed them to be
fitted snugly around the sciatic nerve without constricting
it. The muscle layer was closed with absorbable sutures
(5.0 Vicryl, Ethicon, Johnson & Johnson, Irvine, CA) and
the skin was closed with suture (3.0 Nylon, Ethicon). Tri-
ple antibiotic cream (Bacitracin, Neomycin and Poly-
myxin B, Rite Aid, Harrisburg, PA) was applied over the
wound site. Buprenorphine (0.01 mg/kg, s.c.) was
injected once daily for 2 days for post-surgical analgesia.
Sutures were removed 7–10 days post-surgery under iso-
flurane/N2O anesthesia.
Behavioral testing
Mechanical sensitivity was assessed using an electronic
von Frey hair pressure transducer (IITC Instruments,
Model 1601C, Woodland Hills, CA). Baseline behavioral
testing was performed one day before and on the same
day prior to surgery. Testing was repeated on post-opera-
tive days 1, 2, 3, 4, 5, 7, 9, 11, 13 and 15. The rat was gen-
tly placed in a plastic-walled cage (10 × 20 × 13 cm) with
a metal mesh floor (0.6 × 0.6 cm holes). A point in the
middle of the hindpaw was tested with the tip of the elec-
tronic von Frey hair pressed on the spot until the animal
withdrew the foot. The force (g) applied at the time of
withdrawal was recorded. Each hindpaw was tested three
times at 1 min intervals and the results were averaged for
each paw for that day.
Thermal sensitivity testing was performed using the Har-
greaves paw withdrawal apparatus (Hargreaves Model
390, IITC Instruments) which measures the withdrawal
latency from a radiant heat source directed at the proximal
half of the plantar surface of each hindpaw. The baseline
and post-operative testing schedule was the same as for
mechanical sensitivity. Prior to testing, rats were allowed
to acclimate to the testing environment for 15 min, which
consisted of translucent plastic-walled individual cham-
bers (10 × 20 × 20 cm) and a 3 mm thick glass bottom
(preheated to 30°C). A radiant heat source consisting of
an adjustable infrared lamp and a built-in stopwatch accu-
rate to 0.1 s were used to measure paw withdrawal latency.
Each paw was tested three times at 25% maximal heat
intensity allowing 5 min between each test. The test was
performed only when a rat was stationary and standing on
all four paws. Special care was taken to keep the glass bot-
tom clean and dry during the testing. If the glass needed
to be cleaned during the experiment, the rats were allowed
5–10 min to reacclimatize to the environment. The results
of three tests were averaged for each paw for that day.
DRG extraction and sample collection
At 15–21 days after SNE rats were anesthetized with
sodium pentobarbital (50 mg/kg, i.p.) or alternatively
with a mixture of isoflurane (1–3%), N2O (50%), and O2
(inhalation). The L4 and L5 DRG on both sides were
excised with attached spinal nerves and dorsal roots, and
placed in cold (0–4°C) low-Na+ artificial cerebrospinal
fluid (ACSF) composed of (in mM): KCl 2.5, NaH2PO4
1.25, CaCl2 0.5, MgCl2 3.5, NaHCO3 26, glucose 10 and
sucrose 248. The ACSF was continuously bubbled with a
95/5% mixture of O2/CO2 to ensure adequate oxygena-
tion of ganglia and pH 7.4. The DRG were cleaned of sur-
rounding connective tissue and incubated for 5 minutes at
room temperature in low-Na+ artificial cerebrospinal fluid
(ACSF) composed of (in mM): NaCl 63, KCl 2.5,
NaH2PO4 1.25, CaCl2 0.5, MgCl2 3.5, NaHCO3 26, glu-
cose 10 and sucrose 124 before being placed in the sample
collection chamber where they were slowly (160 μl/min)
perfused with normal ACSF (NaCl 125 and no sucrose) at
35.0 ± 0.5°C. In initial experiments, we used an open
sample collection chamber (custom-made), where DRG
could be monitored for physiological integrity using
extracellular suction electrode recordings of evoked com-
pound action potentials [33]. In subsequent experiments
with adenosine receptor ligands, we switched to a com-
mercial closed chamber (RC-30WA, Warner Instruments)
for better flow and temperature control. High KCl-con-
taining (100 mM) ACSF was applied after the baseline col-
lection. For high K+ solutions, NaCl content was reduced
to maintain ACSF osmolality. 8-Cyclopentyl-1,3-dipro-
pylxanthine (DPCPX, 10 μM in 10% dimethylsulfoxide)
and N6-cyclopentyladenosine (NCPA,10 μM in H2O)
from frozen (-20°C) stock were diluted in ACSF just priorPage 3 of 13
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fusate without DPCPX contained 0.03% dimethylsulfox-
ide.
Samples were collected at 1 min intervals into polypropyl-
ene tubes (0.2 ml; Corning Incorporated, Corning, NY),
immediately frozen in liquid nitrogen and stored at -80°C
until analysis. All experimental samples were analyzed
within 3 days of collection.
Measurement of ATP release
Release of ATP was determined directly using the firefly
luciferin-luciferase (L/L) assay. In initial experiments, L/L
reagent (30 μL, CLS II, Boehringer Mannheim, Man-
nheim, Germany) was added to samples (40 μL) in a
cylindrical cuvette, mixed and placed into a luminometer
(TD-20/20, Turner Designs, Sunnyvale, CA). Chemilumi-
nometer settings were delay: 1 sec, integration: 10 sec. In
experiments with adenosine receptor ligands, samples
were placed in closed-bottom 96-well white polystyrene
plates (Corning Life Sciences, Lowell, MA) in a microplate
reader (Synergy HT, Biotek, Winooski, VT) which auto-
matically dispensed and mixed L/L solutions (ATP Biolu-
minescence kit HS II, Roche Diagnostics, Indianapolis,
IN) to individual wells. Several concentrations of ATP
standard (100 pM – 1 μM) with ACSF were measured
before analysis of each experimental sample set. Separate
ATP standards containing appropriate KCl and/or drug
concentrations were also measured when appropriate.
Microplate reader settings were delay: 0 sec, integration:
15 sec.
Measurement of O2 consumption
The L4 and L5 DRG were obtained from anesthetized rats
as described above and the attached nerves were cut at 10
mm from each side of the DRG. After 15 min incubation
in cold normal ACSF, both DRG were transferred into a
closed chamber (Multi-Port Measurement Chamber;
World Precision Instrument, Sarasota, FL) filled with 2.5
ml of N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic
acid (HEPES, 26 mM)-buffered ACSF. Oxygen consump-
tion was measured with an oxygen probe (ISO2; World
Precision Instruments, Sarasota, FL) which continuously
measured dissolved oxygen in HEPES-buffed ACSF. Once
the chamber temperature reached 34.5 ± 0.4°C, recording
continued for 60 min and later analyzed off-line using the
pCLAMP9 software (Molecular Devices, Union City, CA).
Statistical analysis
All data are presented as mean ± S.E.M. Statistical analyses
(one-way repeated measures ANOVA with post hoc com-
parisons, one-way ANOVA and two-way ANOVA) were
used to compare the data.
Results
Hindpaw withdrawal thresholds after sciatic nerve 
entrapment (SNE)
SNE is a variation on chronic constriction injury in which
the loose ligatures placed around the sciatic nerve are
replaced by fixed-diameter polyethylene cuffs, resulting in
decreased variability across animals [34]. The use of
chemically inert polyethylene also prevents potentially
confounding inflammatory responses that can occur in
response to chromic catgut sutures. Stable baseline meas-
urements were obtained 1 day pre-operatively and on the
day just prior to the operation to both mechanical and
thermal stimuli. Post-operatively (PO), measurements
revealed that the SNE animals developed increased sensi-
tivity of ipsilateral hindpaw to both types of stimuli (Fig.
1). For mechanical sensitivity, the baseline threshold for
withdrawal was 40–45 g prior to surgery, and this was
maintained PO for the contralateral paw and in naïve
(untreated) rats (Fig. 1A). The threshold for the ipsilateral
side dropped significantly to ~20 g by 2 days PO; a change
that was maintained throughout the testing period. Signif-
icant decreases in latency to hindpaw withdrawal from a
thermal stimulus developed by 3 days PO, and the change
in latency was maintained throughout the testing period
(Fig. 1B). There were also signs of spontaneous pain
behaviors which included guarding behavior and changes
in the posture of the affected hindpaw such as plantar flex-
ion and toe-clenching, typical of this model [34].
Basal ATP release from L4/L5 DRG after SNE
Sciatic nerve entrapment leads to axonal injury of neurons
with cell bodies in both L4 and L5 DRG [34], prompting
us to measure ATP release in both L4 and L5 DRG. In these
initial studies, samples collected for the first few minutes
of DRG perfusion had very high ATP content (not shown)
and declined to stable levels by 12–15 min of perfusion.
These initial high levels of ATP are probably due to
mechanical deformation of the DRG preparation [35]
when it was placed in the collection chamber and there-
fore are not included in the experimental analysis. In
some of these experiments we also confirmed the physio-
logical integrity of the DRG preparations by measuring
evoked compound action potentials. The fitting of suction
recording electrodes to spinal nerves and dorsal roots
likely also contributed to the initial high ATP levels. After
establishing a stable baseline, perfusion of naive rat L4
and L5 DRG (n = 20, 10 rats) with 100 mM KCl evoked a
reversible increase in the amount of ATP (Fig. 2A). In a
separate set of experiments, we could not detect KCl-
evoked increases in ATP release from preparations con-
taining either spinal nerves alone or dorsal roots alone
(data not shown), indicating that DRG neuronal somata
are required for KCl-evoked ATP release. Also, we demon-
strated previously that KCl-evoked ATP release in vivo is
dependent on calcium influx through voltage-gated cal-Page 4 of 13
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Increased mechanical and thermal sensitivity after SNE inductionFigure 1
Increased mechanical and thermal sensitivity after SNE induction. A: hindpaw withdrawal thresholds (mean ± S.E.M.) 
to mechanical stimuli on the ipsilateral side (n = 6 rats) are significantly decreased compared to contralateral side and naïve rats 
(n = 6) at 2 days after SNE surgery. Note that the decreases persist to the last day of measurements. B: hindpaw withdrawal 
latency (mean ± S.E.M.) from thermal stimuli on the ipsilateral side is also significantly reduced by the 3rd day after SNE. *, sig-
nificant difference from other group means.
Molecular Pain 2008, 4:66 http://www.molecularpain.com/content/4/1/66cium channels because it could be blocked by cadmium
application [6]. Comparison of the in vitro experimental
data indicated that baseline samples from ipsilateral DRG
of SNE rats (n = 19, 11 rats) had significantly (p < 0.05)
higher ATP levels than samples from control DRG. How-
ever, 100 mM KCl perfusion did not evoke ATP release in
ipsilateral DRG as it did in naive rat DRG (Fig. 2B, D). By
contrast, samples from contralateral DRG had basal levels
of ATP similar to DRG from naive rats and exhibited
robust increases in ATP content after 100 mM KCl per-
fusion (Fig. 2C, D).
Effect of selective A1R activation on basal and KCl-evoked 
ATP release
The differential effects of SNE on basal and evoked ATP
release suggested a possible involvement of ATP metabo-
lites. Normally, extracellular ATP is regulated by the activ-
ity of various ectonucleotidases which convert ATP to di-
and mono-phosphates and subsequently into adenosine.
DRG neurons are endowed with A1Rs whose activation,
in turn, leads to decreased voltage-gated Ca2+ channel
(VGCC) activity [36]. Since KCl-evoked ATP release in
sensory neurons is dependent on VGCC activation [6], we
hypothesized that the block of evoked ATP release after
SNE could result from the conversion of extracellular ATP
to adenosine with subsequent activation of A1Rs on DRG
neurons. To test this hypothesis we first had to demon-
strate that A1R activation can lead to altered ATP release
within DRG. To that end, we compared basal and KCl-
evoked ATP release in DRG from naïve rats in the presence
and absence of the selective A1R agonist, NCPA (100 nM).
In the absence of NCPA (n = 6 DRG, 4 rats), KCl (100
Altered ATP release from DRG after SNE injuryFigure 2
Altered ATP release from DRG after SNE injury. A: ATP release from naive rat DRG is increased by KCl (100 mM) 
stimulation. * denotes p < 0.05 compared with basal ATP levels. Basal release was defined as the average of 4 samples obtained 
1 min prior to onset of KCl stimulation. For clarity, samples 1–9 are not shown. B: Basal ATP release is higher than in naive 
DRG, whereas KCl stimulation no longer evokes ATP release from ipsilateral DRG. C: The pattern of ATP release from con-
tralateral DRG is similar to naive DRG. * denotes p < 0.05 compared with basal ATP level. D: Summary graph of basal and 
evoked ATP release in DRG from naive and SNE neuropathic rats. Data were binned as illustrated in A-C. Note the increased 
basal and loss of KCl-evoked ATP release in ganglia ipsilateral to the SNE.Page 6 of 13
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the sample ATP levels (Fig. 3A, B). However, in the contin-
uous presence of NCPA (n = 7 DRG, 4 rats), there was a
significant decrease in both basal and KCl-evoked ATP
release (Fig. 3A, B), suggesting functional modulation of
ATP release by A1R activation.
Effect of selective A1R blockade on basal and KCl-evoked 
ATP release in DRG ipsilateral to SNE
We next tested our hypothesis by measuring basal and
KCl-evoked ATP release in DRG from neuropathic rats in
the presence and absence of the selective A1R antagonist,
DPCPX. DRG ipsilateral to SNE exhibited higher basal
ATP concentrations than contralateral DRG (compare Fig.
4A with 4C). Also, there was no significant KCl-evoked
ATP release in ipsilateral DRG compared with the contral-
ateral DRG, confirming our initial findings (see Fig. 2). As
we suspected, in the presence of the selective A1R inhibi-
tor, DPCPX (30 nM), both basal and KCl-evoked ATP
release was significantly increased in DRG contralateral to
SNE (compare Fig. 4A with 4B). Blockade of A1Rs in DRG
ipsilateral to SNE further increased basal ATP levels com-
pared to untreated ipsilateral SNE DRG (compare Fig. 4C
with 4D). In support of our hypothesis, we observed a
robust KCl-evoked release of ATP in DRG ipsilateral to
SNE during A1R blockade (Fig. 4D and 4E).
Altered metabolism after SNE
Increases in basal ATP release observed in ipsilateral L4/L5
DRG after SNE suggested possible changes in metabolism.
We reasoned that increased ATP levels could arise from
the demonstrated increases in excitability of both injured
and spared sensory neurons [1], which in turn would
increase the metabolic demand for ATP needed for the
maintenance of ionic gradients. Increased neuronal excit-
ability has been previously linked to increased metabolic
activity in spinal cord neurons of normal rats [37], as well
as after sciatic nerve ligation [38,39]. However, metabolic
changes within sensory ganglia were not examined.
To test whether oxidative metabolism is increased in DRG
ipsilateral to injury, we adapted the in vitro DRG prepara-
tion for measurements of O2 consumption. Since O2 con-
sumption is greatly influenced by factors such as
temperature, etc., particular care was taken to ensure sim-
ilarity of conditions for testing ganglia from different rats.
After the ganglia were placed in the testing chamber, the
one-hour recording began when temperature increased to
a stable level of ≥ 34.5°C. The average temperatures dur-
ing O2 consumption measurements of 34.66 ± 0.15°C
(naive DRG) and 34.53 ± 0.20°C (DRG ipsilateral SNE)
were not significantly different. DRG ipsilateral to SNE
consumed O2 faster than control rat DRG (Fig. 5A). The
rate of O2 consumption (expressed as the rate of negative
redox current increase produced by the O2 probe) in DRG
from naive rats (-24.42 ± 1.14 nA/hr) was significantly dif-
ferent (p = 0.005) from that of DRG ipsilateral to SNE (-
33.18 ± 2.58 nA/hr) (Fig. 5A). In a separate set of experi-
ments, no significant differences were found in the O2
consumption of DRG contralateral to SNE and naive rat
DRG (data not shown).
Discussion
We measured nanomolar ATP levels with the luciferin-
luciferase assay after bulk equilibration of perfusate sam-
ples with the DRG preparation, permitting relative com-
parisons of changes in basal and evoked ATP release after
neuropathy induction. However, these measurements
greatly underestimate the true ATP concentration in the
pericellular environment of DRG either during stimulated
or basal release, because of its rapid degradation by ecto-
nucleotidases and delayed diffusion due to unstirred layer
effects. Recent studies have suggested that true levels of
ATP at the plasma membrane are underestimated by >20-
fold with bulk phase measurements [9]. Thus, based on
measured basal ATP levels in control DRG (Fig. 2A) we
would expect true ATP concentration at the neuronal
plasma membrane to be >10 nM. At this extracellular
[ATP], some degree of P2X3 receptor desensitization
would be expected [40,41]. This might explain the paucity
of ATP (1–10 mM) responsiveness via P2X3Rs in neurons
within intact DRG preparations compared to the robust
responsiveness in acutely dissociated neurons [42].
Several possible explanations could account for the
increased basal ATP release from DRG ipsilateral to SNE.
Previous studies have shown that peripheral denervation
(axotomy) leads to progressive degeneration of ~35% of
DRG neurons [43,44]. Thus, it is conceivable that break-
down of the plasma membrane of degenerating neurons
could lead to spillover of intracellular ATP into the extra-
cellular space where it would contribute to the measured
increases in ATP levels. However, after sciatic nerve con-
striction injury both myelinated and unmyelinated axons
are intact proximal to the constriction site despite damage
to distal axons, indicating the survival of the DRG neurons
whose axons are interrupted [45]. Another possibility
which remains to be examined is a neuropathy-induced
decrease in the ectonucleotidase-mediated degradation of
extracellular ATP [7]. A more plausible explanation might
be that higher extracellular ATP levels result from
increased excitability of both injured and uninjured neu-
rons [1]. Increased neuronal excitability is clearly linked
with increased metabolism [46], which leads to increases
in intracellular ATP levels. In yeast [47], as well as mam-
malian pancreatic β-cells [48-50] and adrenal chromaffin
cells [51], increased metabolism and intracellular ATP
have been linked with increased extracellular ATP release.
Surprisingly, this relationship has not been addressed in
central or peripheral neurons. However, we suspect thatPage 7 of 13
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Selective A1 receptor activation decreases basal and KCl-evoked ATP releaseFigure 3
Selective A1 receptor activation decreases basal and KCl-evoked ATP release. A: Data are presented as mean ± 
SEM of sample ATP levels from naïve rat DRG in normal perfusate (white bars) and in the continuous presence of NCPA (100 
nM, black bars). When DRG are perfused in the presence of NCPA (100 nM) both basal and evoked ATP release is visibly 
decreased. * denotes p < 0.05 compared with basal ATP levels. B: Summary graph of basal and evoked ATP release in DRG 
from naive rats with and without NCPA. Data were binned as illustrated in A.
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Selective A1 receptor blockade increases basal ATP levels and relieves the blockade of KCl-evoked ATP release in DRG ipsilat-eral to SNEFigure 4
Selective A1 receptor blockade increases basal ATP levels and relieves the blockade of KCl-evoked ATP 
release in DRG ipsilateral to SNE. A: Data are presented as mean ± SEM of sample ATP concentration from L4/L5 DRG 
contralateral to SNE before and after KCl (100 mM) application. B: Data from DRG contralateral to SNE during continuous 
presence of DPCPX (30 nM). C: Data from DRG ipsilateral to SNE before and after KCl (100 mM) application. Note the 
absence of KCl-evoked ATP release. D: Data from DRG ipsilateral to SNE during continuous presence of DPCPX (30 nM). E: 
Summary graph of basal and evoked ATP release in DRG from neuropathic rats in the presence and absence of DPCPX. Data 
were binned as illustrated in A-D. Note the DPCPX-induced increases in basal release and recovery of KCl-evoked release of 
ATP in DRG ipsilateral to SNE.
Molecular Pain 2008, 4:66 http://www.molecularpain.com/content/4/1/66the hyperexcitability-induced increases in ATP production
might result in increased vesicular [52] and non-vesicular
release [5] of ATP from somata of DRG neurons.
Evidence in support of this explanation was obtained by
demonstrating that O2 consumption was increased in L4/
L5 ganglia ipsilateral to SNE compared to ganglia from
control rats. Almost all of ATP is produced by mitochon-
dria through aerobic respiration. Since O2 is not stored to
any significant degree by tissues, O2 consumption is pro-
portional to energy generation/metabolism. To our
knowledge, this is the first time this method was used to
examine metabolic changes in sensory ganglia. Previ-
ously, the [14C]-2-deoxyglucose (2-DG) method was used
to study effects of peripheral stimulation in sensory gan-
glia, but only in normal rats [37]. In these studies, electri-
cal stimulation produced a frequency-dependent increase
of glucose utilization in the dorsal horn of the spinal cord,
but not within the ipsilateral DRG, leading authors to sug-
gest that axon terminals and not the cell bodies of sensory
neurons are the sites of enhanced metabolic activity dur-
ing increased functional activity of this pathway [37].
Later, spinal cord metabolism was investigated using the
2-DG method in the rat monoarthritis [53] and sciatic
nerve ligation [38,39] models. Interestingly, these studies
demonstrated increased metabolic activity bilaterally in
the spinal cord of arthritic and neuropathic rats, but
apparently sensory ganglia were not examined [38,39,53].
Our studies do not differentiate between contributions of
the various cell types to extracellular ATP release and
metabolism of the entire DRG preparation. Thus, sympa-
thetic fiber sprouting demonstrated by various groups to
occur in the DRG in response to sciatic nerve injury, espe-
cially after axotomy and deafferentation, [54], could con-
tribute to increased ATP levels via release from
sympathetic nerve terminals. Furthermore, while neurons
are expected to make a large contribution to extracellular
ATP release and O2 metabolism, the involvement of other
cell types is also likely. Satellite 'glial' cells which form a
sheath around the somata of neurons in sensory ganglia
undergo proliferation after axotomy or even mild skin
Increased oxygen consumption of neuropathic DRGFigure 5
Increased oxygen consumption of neuropathic DRG. A: the O2 reduction is described as the mean (thick lines) ± SEM 
(thin lines) redox current (nA) from naive (n = 8) and SNE (n = 6) ganglia. All data were adjusted to 0 nA at time point zero. 
The gradient of O2 reduction (consumption) was significantly faster in DRG ipsilateral to SNE compared to naive DRG (p < 
0.05).Page 10 of 13
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satellite cells after SNE contributes to the measured
increases in extracellular ATP levels and the increases in
O2 consumption.
One method used to study neuronal metabolism is the
histochemical detection of cytochrome oxidase activity,
which is tightly coupled to ATP production [56]. Using
this method, chronic decreases in cytochrome oxidase
activity were observed after axotomy of neurons within
sensory ganglia [57,58]. Loss of peripheral trophic factors
and decreased depolarizing activity (action potential dis-
charge) were proposed to contribute to decreased cyto-
chrome oxidase activity in these cells [57]. These studies
contrast with our data which indicate increased metabo-
lism and basal ATP release in L4/L5 DRGs after SNE. They
also contrast with the demonstrated hyperexcitability of
neurons within axotomized DRG in electrophysiological
studies [1,59-61]. One likely explanation for the differ-
ences is that axotomy results in the loss of a vast majority
of the sensory neuron total cytoplasmic mass [62]. Those
neurons which survive axotomy have a greatly decreased
metabolic demand in maintaining a much shorter periph-
eral axon.
In addition to increased basal ATP levels, we no longer
observed a KCl-evoked release of ATP after SNE. Previ-
ously, we used in vivo microdialysis in trigeminal ganglia
to show that large increases in extracellular ATP levels
result in the apparent loss of KCl-evoked ATP release [6].
Others have demonstrated in different tissues that
increases in extracellular ATP lead to increased levels of its
various metabolites, including adenosine [63-65]. Also,
the release of adenosine from primary sensory neurons is
increased in the ipsilateral hindpaw after spinal nerve liga-
tion [31]. Based on these data we reasoned that SNE-
induced increases in extracellular ATP levels should also
result in increased extracellular adenosine levels. KCl-
evoked ATP release in vivo is dependent on the activation
of voltage-gated Ca2+ channels (VGCCs) [6] and VGCCs
are coupled to A1Rs in sensory neurons [36]. A1R activa-
tion leads to decreased Ca2+ influx through VGCCs and
subsequent decreases in evoked transmitter release in
these and other peripheral or CNS neurons [36,66].
Therefore, we hypothesized that the differential SNE
effects on basal and evoked ATP release could result from
the conversion of extracellular ATP to adenosine with sub-
sequent activation of A1Rs on DRG neurons. To test this
hypothesis, we first demonstrated that selective neuronal
A1R activation decreases both basal and evoked ATP
release in DRG from naïve rats (Fig. 3). Then we demon-
strated that selective A1R blockade was able to increase
basal ATP levels in DRG both ipsilateral and contralateral
to SNE, but more importantly relieved the blockade of
KCl-evoked ATP release in DRG ipsilateral to SNE (Fig. 4).
These data support our hypothesis that blockade of
evoked ATP release is caused by increased A1R activation.
An alternative that remains to be explored is that
increased P2Y1 receptor activation also contributes to the
neuropathy-induced blockade of KCl-evoked ATP release.
The findings of increased metabolism and ATP release in
sensory ganglia after peripheral nerve injury have several
implications for neuropathic pain mechanisms. Increased
extracellular ATP may directly activate neighboring sen-
sory afferents through P2XRs [14,15] thereby increasing
nociceptive drive to the CNS. ATP release and P2X-medi-
ated signaling also participate in the enhancement of
glutamatergic neurotransmission at the central terminals
of primary sensory neurons [67,68]. There is also evidence
that peripheral increases in extracellular adenosine may
contribute to hyperexcitability of human sensory axons
via adenosine A2AR activation [69]. This may be tem-
pered by increased activation of 'inhibitory' A1Rs at
peripheral, spinal and supraspinal locations [28,70,71].
Increased activation of P2Y1Rs may also contribute to
inhibition of neuronal hyperexcitability [24]. ATP may
also potentiate TRPV1 activity, increase axonal transport
and increase excitability via activation of P2Y2Rs which
likely contributes to nociceptive signaling and hyperalge-
sia after peripheral nerve injury [72-75]. Thus, SNE neu-
ropathy-induced increases in ATP metabolism and release
may contribute to enhanced generation and transmission
of nociceptive signals at peripheral terminals, along the
axons, within the DRG and at central terminals of primary
sensory neurons.
In conclusion, we demonstrated that DRG neurons
exhibit increased metabolic rates, increased extracellular
ATP levels and increased A1R activation on the side of
neuropathy induced by sciatic nerve entrapment. These
data add to the literature supporting the use of selective
purinoceptor ligands and purine metabolism inhibitors
for the therapy of neuropathic pain symptoms [28,76,77].
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